An independent assessment of AI for prostate cancer detection - Case Study
Aug. 31, 2022
Courtesy ofPaige AI, Inc.
Yale Medicine, an academic medical center with a high volume of prostate biopsies, conducted a study to determine Paige Prostate’s utility as a prescreening tool for clinical use. A total of 1,876 prostate core biopsy slides were analyzed by Paige Prostate, and only those cores categorized by the AI as “suspicious” or as out of distribution were manually reviewed by Yale pathologists.
Most popular related searches
Stay in the loop!
Select your areas of interest to receive industry updates.